{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:24:15Z","timestamp":1792794255665,"version":"4.5.0"},"reference-count":73,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/21\/001\/1149"],"award-info":[{"award-number":["SUB\/1\/DN\/21\/001\/1149"]}],"id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis (PSO) is a common skin disease that affects about 1%\u20133% of the general population. It is a great medical, social and economic burden since PSO is associated with many comorbidities, of which the most common are cardiometabolic disorders. Psoriatic patients suffer more frequently from obesity, dyslipidemia, atherosclerosis, and nonalcoholic fatty liver disease. Research shows that lipid expression and metabolism disorders are present more often in such patients. This review focuses on a variety of aberrations in lipids in the skin, blood, and adipose tissue in psoriatic patients and their multifactorial impact on the pathogenesis of psoriasis.<\/jats:p>","DOI":"10.3390\/ijms22126561","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T11:19:20Z","timestamp":1624015160000},"page":"6561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Aberrations in Lipid Expression and Metabolism in Psoriasis"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-1167","authenticated-orcid":false,"given":"Julia","family":"Nowowiejska","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-9960","authenticated-orcid":false,"given":"Anna","family":"Baran","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St, 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Shih, C.M., Chen, C.C., Chu, C.K., Wang, K.H., Huang, C.Y., and Lee, A.W. (2020). The Roles of Lipoprotein in Psoriasis. Int. J. Mol. Sci., 2.","DOI":"10.3390\/ijms21030859"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hirotsu, C., Rydlewski, M., Ara\u00fajo, M.S., Tufik, S., and Andersen, M.L. (2012). Sleep loss and cytokines levels in an experimental model of psoriasis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051183"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5114\/dr.2020.95258","article-title":"Psoriasis. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1","volume":"107","author":"Reich","year":"2020","journal-title":"Dermatol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., Lewoc, M., Grabowska, P., Kaminski, T.W., and Flisiak, I. (2021). The Assessment of Risk and Predictors of Sleep Disorders in Patients with Psoriasis\u2014A Questionnaire-Based Cross-Sectional Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040664"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Baran, A., Nowowiejska, J., Krahel, J.A., Kaminski, T.W., Maciaszek, M., and Flisiak, I. (2020). Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134594"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis","volume":"6","author":"Zeng","year":"2017","journal-title":"Gigascience"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5114\/dr.2020.103887","article-title":"Psoriasis and cardiometabolic disorders","volume":"107","author":"Nowowiejska","year":"2020","journal-title":"Dermatol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gonzalez-Cantero, A., Gonzalez-Cantero, J., Sanchez-Moya, A.I., Perez-Hortet, C., Arias-Santiago, S., Schoendorff-Ortega, C., and Gonzalez-Calvin, J.L. (2019). Subclinical atherosclerosis in psoriasis. Usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0211808"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5114\/dr.2016.61780","article-title":"The impact of obesity on psoriasis","volume":"103","author":"Krasowska","year":"2016","journal-title":"Dermatol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.13000","article-title":"Effect of the FTO rs9930506 polymorphism on obesity and the main clinical outcomes in patients with psoriasis","volume":"171","author":"Eiris","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdermsci.2008.04.016","article-title":"Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population","volume":"52","author":"Jin","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3389\/fimmu.2019.01507","article-title":"An Update on the Role of Adipose Tissues in Psoriasis","volume":"10","author":"Wong","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, D., Fazekas, F., Ol\u00e1h, A., and T\u00f6r\u0151csik, D. (2020). Adipokines in the Skin and in Dermatological Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239048"},{"key":"ref_17","first-page":"413","article-title":"Role of adiponectin in psoriasis","volume":"97","author":"Baran","year":"2010","journal-title":"Dermatol. Rev."},{"key":"ref_18","first-page":"101","article-title":"Effect of psoriasis activity on serum adiponectin and leptin levels","volume":"32","author":"Baran","year":"2015","journal-title":"Adv. Dermatol. Alergol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1871525713666141218163425","article-title":"Pathophysiology of Atherosclerotic Plaque Development","volume":"13","author":"Rognoni","year":"2015","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5114\/dr.2014.46953","article-title":"Psoriasis as a risk factor of cardiovascular diseases","volume":"101","author":"Komorowska","year":"2014","journal-title":"Dermatol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ad.2016.12.017","article-title":"Psoriasis and Nonalcoholic Fatty Liver Disease","volume":"108","author":"Carrascosa","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mantovani, A., Gisondi, P., Lonardo, A., and Targher, G. (2016). Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020217"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s10067-019-04646-7","article-title":"Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients","volume":"38","author":"Ortolan","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0923-1811(90)90005-X","article-title":"Differences in low density lipoprotein receptor expression in the suprabasal layer of normal and psoriatic epidermis","volume":"1","author":"Mommaas","year":"1990","journal-title":"J. Dermatol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jid.2018.02.003","article-title":"Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood","volume":"138","author":"Sorokin","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/exd.13362","article-title":"Expression of low-density lipoprotein-related receptors 5 and 6 (LRP5\/6) in psoriasis skin","volume":"26","author":"Duvetorp","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pathol.2018.11.003","article-title":"Lipoprotein(a) catabolism: A case of multiple receptors","volume":"51","author":"McCormick","year":"2019","journal-title":"Pathology"},{"key":"ref_29","first-page":"27","article-title":"Galectin 1 in dermatology: Current knowledge and perspectives","volume":"28","author":"Pasmatzi","year":"2019","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02505046","article-title":"Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis","volume":"288","author":"Prens","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamadermatol.2019.3595","article-title":"Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis","volume":"156","author":"Dey","year":"2020","journal-title":"JAMA Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Shih, C.M., Huang, C.Y., Wang, K.H., Huang, C.Y., Wei, P.L., Chang, Y.J., Hsieh, C.K., Liu, K.T., and Lee, A.W. (2018). Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Expression In Vivo and In Vitro. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092610"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.18632\/aging.103665","article-title":"Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: Regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-\u03b2\/\u03b4 and PPAR-\u03b3","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5114\/dr.2017.71834","article-title":"The role of lipids in psoriasis","volume":"104","author":"Baran","year":"2017","journal-title":"Dermatol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free Fatty Acid Receptors in Health and Disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"19295","DOI":"10.1038\/srep19295","article-title":"Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis","volume":"6","author":"Varshney","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cjca.2013.04.007","article-title":"The relationship between skin cholesterol testing and parameters of cardiovascular risk: A systematic review","volume":"29","author":"Tashakkor","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000441540","article-title":"Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients","volume":"49","author":"Bouwstra","year":"2016","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3346\/jkms.2007.22.5.862","article-title":"A study on altered expression of serine palmitoyltransferase and ceramidase in psoriatic skin lesion","volume":"22","author":"Hong","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-\u03b3 decreases ceramides with long-chain fatty acids: Possible involvement in atopic dermatitis and psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.20080129","article-title":"Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment","volume":"206","author":"Albanesi","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_43","unstructured":"Kiluk, P., Baran, A., Kaminski, T., Maciaszek, M., and Flisiak, I. (2021). Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: Preliminary results. Adv. Dermatol. Allergol., 1\u20139. in press."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1096\/fasebj.14.3.565","article-title":"Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D","volume":"14","author":"Chen","year":"2000","journal-title":"FASEB J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"692","DOI":"10.5114\/ada.2019.91420","article-title":"Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: A systematic review and meta-analysis of case-control studies","volume":"36","author":"Ramezani","year":"2019","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5114\/ada.2018.78028","article-title":"Serum concentration of interleukin 6 is related to inflammation and dyslipidemia in patients with psoriasis","volume":"37","author":"Pietrzak","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fendo.2014.00186","article-title":"Free fatty acids and their metabolism affect function and survival of podocytes","volume":"5","author":"Sieber","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00403-017-1748-x","article-title":"Serum fatty acid profile in psoriasis and its comorbidity","volume":"309","author":"Baran","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5114\/ada.2020.98284","article-title":"Pathogenesis of psoriasis in the \u201comic\u201d era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis in psoriasis","volume":"37","author":"Nedoszytko","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_50","first-page":"244","article-title":"Novel inflammatory markers in psoriasis vulgaris: Vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40","volume":"151","author":"Ataseven","year":"2016","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"109336","DOI":"10.1016\/j.cellsig.2019.06.001","article-title":"Role of fatty acid binding proteins (FABPs) in cancer development and progression","volume":"62","author":"McKillop","year":"2019","journal-title":"Cell Signal."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00403-019-01917-w","article-title":"Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis","volume":"311","author":"Baran","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/lipd.12173","article-title":"Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin","volume":"54","author":"Baran","year":"2019","journal-title":"Lipids"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11745-016-4211-4","article-title":"Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis","volume":"52","author":"Baran","year":"2017","journal-title":"Lipids"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/1346-8138.14647","article-title":"Intestinal barrier integrity in patients with plaque psoriasis","volume":"45","author":"Sikora","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/jid.2010.342","article-title":"Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-\u03baB signaling pathway","volume":"131","author":"Ogawa","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tcm.2019.01.001","article-title":"Effect of statins on atherosclerotic plaque","volume":"29","author":"Almeida","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic Effects of Statins on the Cardiovascular System","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3889\/oamjms.2019.060","article-title":"Efficacy of adding oral simvastatin to topical therapy for treatment of psoriasis: The vietnamese experience","volume":"7","author":"Trong","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14779072.2017.1408410","article-title":"Fibrates in the management of atherogenic dyslipidemia","volume":"15","author":"Buldak","year":"2017","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_61","first-page":"623","article-title":"Clofibrate treatment of psoriasis with hypertriglycemia--clinical, histological and laboratory analysis","volume":"101","author":"Imamura","year":"1991","journal-title":"Nihon Hifuka Gakkai Zasshi"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Krahel, J.A., Baran, A., Kami\u0144ski, T.W., Maciaszek, M., and Flisiak, I. (2020). Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040910"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Amoruso, G.F., Nistic\u00f2, S.P., Iannone, L., Russo, E., Rago, G., Patruno, C., and Bennardo, L. (2021). Ixekizumab May Improve Renal Function in Psoriasis. Healthcare, 9.","DOI":"10.3390\/healthcare9050543"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Iannone, L.F., Bennardo, L., Palleria, C., Roberti, R., De Sarro, C., Naturale, M.D., Dastoli, S., Donato, L., Manti, A., and Valenti, G. (2020). Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241575"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e14504","DOI":"10.1111\/dth.14504","article-title":"Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising","volume":"33","author":"Dattola","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/met.2019.0092","article-title":"Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study","volume":"18","author":"Botelho","year":"2020","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jdv.16004","article-title":"Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients","volume":"34","author":"Gerdes","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaad.2018.02.074","article-title":"Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3","volume":"79","author":"Egeberg","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12944-021-01441-9","article-title":"Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients","volume":"20","author":"Cao","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cyto.2015.03.009","article-title":"Regulation of IL-17 in atherosclerosis and related autoimmunity","volume":"74","author":"Ryu","year":"2015","journal-title":"Cytokine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2017.07.002","article-title":"Serum IL-10, IL-17 and IL-23 levels as \u201cbioumoral bridges\u201d between dyslipidemia and atopy","volume":"99","author":"Manti","year":"2017","journal-title":"Cytokine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jid.2019.07.679","article-title":"A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)","volume":"140","author":"Gelfand","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e011199","DOI":"10.1161\/CIRCIMAGING.120.011199","article-title":"Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational Study","volume":"13","author":"Choi","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:18:35Z","timestamp":1760163515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/12\/6561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":73,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22126561"],"URL":"https:\/\/doi.org\/10.3390\/ijms22126561","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]}}}